- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Charles River Laboratories (CRL)
Charles River Laboratories stock price live, this page displays NYSE CRL stock exchange data. View the CRL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Charles River Laboratories real time stock price chart below.
What Is the Charles River Laboratories Stock Price Today?
The Charles River Laboratories stock price today is 167.95.
What Is the Stock Symbol for Charles River Laboratories?
The stock symbol for Charles River Laboratories is ""CRL.""
What Stock Exchange Does Charles River Laboratories Trade On?
Charles River Laboratories is listed and trades on the NYSE stock exchange.
Is Charles River Laboratories a Good Stock to Buy?
Determining whether Charles River Laboratories—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRL quote. (ISIN: US1598641074)
What Is the Charles River Laboratories Stock Price Today?
The Charles River Laboratories stock price today is 167.95.
What Is the Stock Symbol for Charles River Laboratories?
The stock symbol for Charles River Laboratories is ""CRL.""
What Stock Exchange Does Charles River Laboratories Trade On?
Charles River Laboratories is listed and trades on the NYSE stock exchange.
Is Charles River Laboratories a Good Stock to Buy?
Determining whether Charles River Laboratories—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CRL quote. (ISIN: US1598641074)
167.95
+4.59(+2.81%)
Closed·
After Hours
171.10+3.15(+1.88%)
·
Fair Value
An estimate of a Charles River Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
165.88
169.60
52 wk Range
91.86
254.15
CRL Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 14 days
More Info
Fair Value
An estimate of a Charles River Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
165.88169.60
52 wk Range
91.86254.15
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CRL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Charles River Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
160.55
Downside
-4.40%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Charles River Laboratories Company Profile
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Charles River Laboratories Earnings Call Summary for Q1/2025
- Charles River Labs beats Q1 2025 expectations with EPS of $2.34 and revenue of $984.2M, stock surges 14.92% pre-market
- Company raises full-year guidance, projecting EPS of $9.30-$9.80 despite anticipated organic revenue decline of 2.5-4.5%
- Alternative Methods Advancement Project launched, contributing $200M in annual revenue; focus on expanding non-animal platforms
- Operating margin improves to 19.1%; free cash flow increases to $112.4M from $50.7M last year
- Potential $50M revenue impact from reduced chronic NHP studies due to FDA's animal testing reduction initiative
Last Updated: 07/05/2025, 16:16
Read Full TranscriptCompare CRL to Peers and Sector
Metrics to compare | CRL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −261.3x | 23.9x | −0.5x | |
PEG Ratio | 2.37 | −0.55 | 0.00 | |
Price/Book | 2.6x | 3.1x | 2.6x | |
Price / LTM Sales | 2.1x | 2.1x | 3.2x | |
Upside (Analyst Target) | −3.0% | 2.5% | 42.7% | |
Fair Value Upside | Unlock | −4.7% | 5.8% | Unlock |
Analyst Ratings
5 Buy
13 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 160.55
(-4.40% Downside)
Earnings
Latest Release
May 07, 2025
EPS / Forecast
2.34 / 2.09
Revenue / Forecast
984.20M / 941.47M
People Also Watch
FAQ
What Stock Exchange Does Charles River Laboratories Trade On?
Charles River Laboratories is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Charles River Laboratories?
The stock symbol for Charles River Laboratories is "CRL."
What Is the Charles River Laboratories Market Cap?
As of today, Charles River Laboratories market cap is 8.21B.
What Is Charles River Laboratories's Earnings Per Share (TTM)?
The Charles River Laboratories EPS (TTM) is -0.62.
When Is the Next Charles River Laboratories Earnings Date?
Charles River Laboratories will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is CRL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Charles River Laboratories Stock Split?
Charles River Laboratories has split 0 times.
How Many Employees Does Charles River Laboratories Have?
Charles River Laboratories has 19400 employees.
What is the current trading status of Charles River Laboratories (CRL)?
As of 23 Jul 2025, Charles River Laboratories (CRL) is trading at a price of 167.95, with a previous close of 163.36. The stock has fluctuated within a day range of 165.88 to 169.60, while its 52-week range spans from 91.86 to 254.15.
What Is Charles River Laboratories (CRL) Price Target According to Analysts?
The average 12-month price target for Charles River Laboratories is USD160.55353, with a high estimate of USD200 and a low estimate of USD70. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -4.40% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.